Benzodiazepine receptor quantification in Huntington's disease with [(123)I]iomazenil and SPECT

OBJECTIVES—Increasing evidence suggests that metabolic changes predate neuronal death in Huntington's disease and emission tomography methods (PET and SPECT) have shown changes in glucose consumption and receptor function in early and possibly even presymptomatic disease. Because the GABA(A)-be...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Pinborg, L, Videbak, C, Hasselbalch, S, Sorensen, S, Wagner, A, Paulson, O, Knudsen, G
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Group 2001
Témata:
Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1737353/
https://ncbi.nlm.nih.gov/pubmed/11309461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.70.5.657
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky